Dr. Kaur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd St
Hackensack, NJ 07601Phone+1 551-996-8297Fax+1 551-996-0575
Summary
- I am a board certified Hematologist/Oncologist currently practicing in the Bone Marrow Transplant division at John Theurer Cancer Center/Hackensack University Medical Center
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2016 - 2019
- Drexel University College of Medicine/Hahnemann University HospitalChief Residency, Internal Medicine, 2015 - 2016
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2012 - 2015
- Ross University School of MedicineClass of 2012
Certifications & Licensure
- NJ State Medical License 2016 - 2025
- PA State Medical License 2012 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma Start of enrollment: 2010 Apr 08
Publications & Presentations
PubMed
- Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after...Scott D Rowley, Thomas S Gunning, Michael Pelliccia, Alexandra Della Pia, Albert Lee
Cancers. 2024-03-29 - 20 citationsClinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.Michele L. Donato, Steven I. Park, Melissa Baker, Robert Korngold, Alison Morawski
JCI Insight. 2021-03-22
Abstracts/Posters
- Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor ...Sukhdeep Kaur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Building international partnerships to improve global oncological care: Perspective from Rutgers-CINJ Global Oncology Fellowship Program.Ashwin Chandar, Sukhdeep Kaur, et al., 2019 ASCO Quality Care Symposium, San Diego, CA, 9/6/2019
- Evaluating the Challenges of Cancer Care in Botswana- Chemotherapy Utilization and Stock Outs.Sukhdeep Kaur, American Society of Clinical Oncology, Chicago, Il, 6/2019
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Punjabi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: